Company profile: WIL Research
1.1 - Company Overview
Company description
- Provider of global Contract Research Organization (CRO) services, offering discovery support services, product safety toxicological research, metabolism, bioanalytical chemistry, analytical chemistry, and formulation services.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to WIL Research
Vial
HQ: United States
Website
- Description: Provider of advanced programs for clinics to conduct lower-cost trials, specializing in computationally designed therapeutics and leveraging technology to automate clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vial company profile →
Vibalogics
HQ: Germany
Website
- Description: Provider of contract development and manufacturing services for live biological products, including process development, manufacturing and fill & finish for oncolytic viruses, gene therapies and vaccines. Capabilities span viral vector and live virus production, RNA and LNP manufacturing, plasmid development and manufacturing, upstream/downstream and formulation development, and cGMP manufacturing for phase 1–2 clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vibalogics company profile →
Nutrasource
HQ: Canada
Website
- Description: Provider of clinical trial management, regulatory support, third-party certification programs for natural ingredients (NutraStrong, IFOS, IKOS, IAOS, IGEN, IPRO, Radioactivity Tested & Certified), analytical method development, quality control release testing, and formulation validation support testing to help health product companies bring products to market with trust, confidence, strong science, and regulatory credibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutrasource company profile →
Oncodesign Services
HQ: France
Website
- Description: Provider of CRO drug discovery and preclinical services from target identification to IND filing in oncology, inflammation and infectious diseases. Services span small-molecule discovery (PROTAC, molecular radiotherapy; hit finding, lead optimization, candidate generation), preclinical proof of concept (oncology, inflammation, COVID-19; pharmacology imaging, DMPK, microbiome), IND support (toxicology, CMC), bioanalysis, in vitro assays, and pharmaco-imaging.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oncodesign Services company profile →
Curapath
HQ: Spain
Website
- Description: Provider of polymer and lipid-based drug delivery systems—including polymer and lipid nanoparticles—offering custom design through preclinical development to commercial-scale pharmaceutical manufacturing, plus drug conjugation and cross-linking services to enhance stability, reduce toxicity, and improve bioactivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Curapath company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for WIL Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to WIL Research
2.2 - Growth funds investing in similar companies to WIL Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for WIL Research
4.2 - Public trading comparable groups for WIL Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →